Improved in vitro and in vivo cutaneous delivery of protoporphyrin IX from PLGA-based nanoparticles

Photochemistry and Photobiology

Volumn 89, Issue 5, 2013, Pages 1176-1184

  Da Silva, Carolina L ^a   Del Ciampo, José O ^b   Rossetti, Fábia C ^b   Bentley, Maria V L B ^b   Pierre, Maria B R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

DRUG CARRIER; LACTIC ACID; NANOPARTICLE; PHOTOSENSITIZING AGENT; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PROTOPORPHYRIN;

ANIMAL; ARTICLE; CHEMISTRY; HAIRLESS MOUSE; IN VITRO STUDY; METABOLISM; MOUSE; PERMEABILITY; SKIN;

ANIMALS; DRUG CARRIERS; LACTIC ACID; MICE; MICE, HAIRLESS; NANOPARTICLES; PERMEABILITY; PHOTOSENSITIZING AGENTS; POLYGLYCOLIC ACID; PROTOPORPHYRINS; SKIN;

EID: 84884163485     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/php.12121     Document Type: Article

References (51)

1. Braathen, L. R., R. M. Szeimies, N. Basset-Seguin, R. Bissonnette, P. Foley, D. Pariser, R. Roelandts, A. M. Wennberg, and, C. A. Morton, (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J. Am. Acad. Dermatol. 56, 125-143.
2. Morton, C. A., K. E. McKenna, and, R. E. Rhodes, (2008) Guidelines for topical photodynamic therapy: update. Br. J. Dermatol. 59, 1245-1266.
3. Sidoroff, A., and, P. Thaler, (2010) Taking treatment decisions in non-melanoma skin cancer-the place for topical photodynamic therapy (PDT). Photodiagnosis Photodyn. Ther. 7, 24-32.
4. Battle, A., and, Q. Peng, (2007) Preface: special issue of photodynamic therapy and photodetection with porphyrin precursors for the journal of environmental pathology, toxicology, and oncology. J. Environ. Pathol. Toxicol. Oncol. 26, ix-xii.
5. Pierre, M. B. R., A. C. Tedesco, J. M. Marchetti, and, M. V. L. B. Bentley, (2001) Stratum corneum lipid liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol. 1, 5.
6. Pierre, M. B. R., E. Ricci Jr, A. C. Tedesco, and, M. V. L. B. Bentley, (2006) Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm. Res. 23, 360-366.
7. Bonnet, R., (1995) Photosensitizers of porphyrins and phthalocianine series for photodynamic therapy. Chem. Soc. Rev. 24, 19-33.
8. Lopez, R. F. V., R. Lange, R. Guy, and, M. V. L. Bentley, (2004) Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Deliv. Rev. 56, 77-94.
9. Paszko, E., C. Ehrhardt, M. O. Senge, D. P. Kelleher, and, J. V. Reynolds, (2011) Nanodrug applications in photodynamic therapy. Photodiagn. Photodyn. Ther. 8, 14-29.
10. Derycke, A. S. L., and, P. A. M. Witte, (2004) Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 56, 17-30.
11. Turchiello, R. F., F. C. B. Vena, P. H. Maillard, C. S. Souza, M. V. L. B. Bentley, and, A. C. Tedesco, (2003) Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). J. Photochem. Photobiol. B: Biol. 70, 1-6.
12. Bender, J., M. B. Ericson, N. Merclin, V. Iani, A. Rosén, S. Engström, and, J. Moan, (2005) Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J. Control Release 106, 350-360.
13. Zhang, G. D., A. Harada, N. Nishiyama, D. L. Jiang, H. Koyama, T. Aida, and, K. Kataoka, (2003) Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer. J. Control Release 93, 141-150.
14. Tekade, R. K., P. V. Kumar, and, N. K. Jain, (2009) Dendrimers in oncology: an expanding horizon. Chem. Rev. 109, 49-87.
15. Bechet, D., P. Couleaud, C. Frochot, M. L. Viriot, F. Guillemin, and, M. Barberi-Heyob, (2008) Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 6, 612-621.
16. Oo, M. K., X. Yang, H. Du, and, H. Wang, (2008) 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine 6, 777-786.
17. Rossi, L. M., P. R. Silva, L. L. Vono, A. U. Fernandes, D. B. Tada, and, M. S. Baptista, (2008) Protoporphyrin IX nanoparticle carrier: preparation, optical properties, and singlet oxygen generation. Langmuir 24, 12534-12538.
18. Peng, C. L., L. Y. Yang, T. Y. Luo, P.-S. Ping-Shan Lai, S.-J. Yang, W.-J. Lin, and, M.-J. Shieh, (2010) Development of pH sensitive 2-(diisopropylamino) ethyl methacrylate based nanoparticles for photodynamic therapy. Nanotechnology 21, 155103.
19. Li, B., E. H. Moriyama, F. Li, M. T. Jarvi, C. Allen, and, B. C. Wilson, (2007) Diblock copolymer micelles deliver hydrophobic protoporphyrin IX for photodynamic therapy. Photochem. Photobiol. 83, 1505-1512.
20. Konan, Y. N., M. Berton, R. Gurny, and, E. Allemann, (2003) Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl) phorphyrin by incorporation into sub-200 nm nanoparticles. Eur. J. Pharm. Sci. 18, 241-249.
21. Chatterjee, D. K., L. S. Fong, and, Y. Zhang, (2008) Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev. 60, 1627-1637.
22. Kumari, A., S. K. Yadav, and, S. C. Yadav, (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B: Biointerfaces 75, 1-18.
23. Miyazaki, S., A. Takahashi, W. Kubo, J. Bachynsky, and, R. Löbenberg, (2003) Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J. Pharm Pharm. Sci. 6, 238-245.
24. Alvarez-Román, R., A. Naik, Y. N. Kalia, R. H. Guy, and, H. Fessi, (2004) Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res. 21, 1818-1825.
25. Alvarez-Román, R., A. Naik, Y. N. Kalia, R. H. Guy, and, H. Fessi, (2004) Skin penetration and distribution of polymeric nanoparticles. J. Control Release 99, 53-62.
26. Luengo, J., B. Weiss, M. Schneider, A. Ehlers, F. Stracke, K. König, K.-H. Kostka, C.-M. Lehr, and, U. F. Schaefer, (2006) Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 19, 190-197.
27. Lademann, L., H. Richter, A. Teichmann, N. Otberg, U. Blume-Peytavi, J. Luengo, B. Weiss, U. F. Schaefer, C. M. Lehr, R. Wepf, and, W. Sterry, (2007) Nanoparticles-An efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 66, 159-164.
28. Castano, A. P., T. Demidova, and, M. R. Hamblin, (2005) Mechanisms in photodynamic therapy: party one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Potodyn. Ther. 2, 91-106.
29. Harrison, S. M., B. W. Barry, and, P. H. Dugard, (1984) Effect of freezing on human skin permeability. J. Pharm. Pharmacol. 35, 261-262.
30. Lopez, R. F. V., M. V. L. B. Bentley, M. B. Delgado-Charro, and, R. H. Guy, (2001) Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm. Res. 18, 311-315.
31. Rossetti, F. C., L. V. Depieri, A. C. Tedesco, and, M. V. L. B. Bentley, (2010) Fluorometric quantification of protoporphyrin IX in porcine skin and phosphate buffer samples from in vitro penetration/permeation studies. Braz. J. Pharm. Sci. 46, 753-760.
32. De Rosa, F. S., R. F. Lopez, J. A. Thomazine, A. C. Tedesco, N. Lange, and, M. V. Bentley, (2004) In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies. Pharm. Res. 21, 2247-2252.
33. Rossetti, F. C., A. R. H. Carollo, J. A. Thomazini, A. C. Tedesco, and, M. V. L. B. Bentley, (2011) A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy. J. Control Release 155, 400-408.
34. Bilati, U., E. Allwmann, and, E. Doelker, (2005) Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur. J. Pharm. Sci. 24, 67-75.
35. Feng, S., and, G. Huang, (2001) Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J. Control Release 71, 53-69.
36. Lee, S. J., K. Park, Y.-K. Oh, S.-H. Kwon, S. Her, I.-S. Kim, K. Choi, S. J. Lee, H. Kim, S. G. Lee, K. Kim, and, I. C. Kwon, (2009) Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials 30, 2929-2939.
37. Jiménez, M. M., J. Pelletier, M. F. Bobin, and, M. C. Martini, (2004) Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int. J. Pharm. 272, 45-55.
38. Shim, J., H. S. Kang, W.-S. Park, S.-H. Han, J. Kim, and, I.-S. Chang, (2004) Transdermal delivery of minoxidil with block copolymer nanoparticles. J. Control Release 97, 477-484.
39. Kim, D. G., Y. I. Jeong, C. Choi, S.-H. Rohb, S.-K. Kangc, M.-K. Jang, and, J.-W. Nah, (2006) Retinol-encapsulated low molecular water-soluble chitosan nanoparticles. Int. J. Pharm. 319, 130-138.
40. Lince, F., D. L. Marchisio, and, A. A. Barresi, (2008) Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications. J. Colloid Interface Sci. 322, 505-515.
41. Mora-Huertas, C. E., H. Fessi, and, A. Elaissari, (2010) Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 385, 113-142.
42. Scolaro, L. M., M. Castriciano, A. Romeo, S. Patané, E. Cefalì, and, M. Allegrini, (2002) Aggregation behavior of protoporphyrin IX in aqueous solutions: clear evidence of vesicle formation. J. Phys. Chem. B 106, 2453-2459.
43. Wischke, C., and, S. P. Schwendeman, (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm. 364, 298-327.
44. Naraharisetti, P. K., M. D. N. Lew, Y. Fu, D. Lee, and, C. Wang, (2005) Gentamicin loaded discs and microspheres and their modifications: characterization and in vitro release. J. Control Release 102, 345-359.
45. De Jalon, E. G., M. J. Blanco-Prieto, P. Ygartua, and, S. Santoyo, (2001b) Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers. J. Control Release 75, 191-197.
46. Costa, P., and, J. M. Sousa Lobo, (2001) Modeling and comparision of dissolution profiles. Eur. J. Pharm. Sci. 13, 123-133.
47. Alves, M. P., A. L. Scarrone, M. Santos, A. R. Pohlmann, and, S. S. Guterres, (2007) Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int. J. Pharm. 341, 215-220.
48. Liu, J., W. Hu, H. Chen, Q. Ni, H. Xu, and, X. Yang, (2007) Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328, 191-195.
49. Otberg, N., H. Richter, H. Schaefer, U. Blume-Peytavi, W. Sterry, and, J. Lademann, (2004) Variations of hair follicle size and distribution in different body sites. J. Invest. Dermatol. 122, 14-19.
50. De Jalon, E. G., M. J. Blanco-Prieto, P. Ygartua, and, S. Santoyo, (2001a) PLGA microparticles: possible vehicles for topical drug delivery. Int. J. Pharm. 226, 181-184.
51. Gerscher, S., J. P. Connelly, G. M. Beijersbergen Van Henegouwen, A. J. MacRobert, P. Watt, and, L. E. Rhodes, (2001) A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and -aminolaevulinic acid-n-pentylester. Br. J. Dermatol. 144, 983-990.